Home >
Products in Development
Text Size make text size smaller make text size largerPrint print this page
Click on compounds in pipeline
for more information

Products in Development

COMPOUND DISCOVERY PRECLINICAL PHASE 1 PHASE 2 PHASE 3
Vosaroxin          
Acute Myeloid Leukemia bar graph chart element bar graph chart element bar graph chart element bar graph chart element bar graph chart element
Platinum-Resistant Ovarian Cancer bar graph chart element bar graph chart element bar graph chart element bar graph chart element  
Vosaroxin (formerly Voreloxin)

Advanced Hematologic and Solid Tumor Malignancies

Ongoing Partnered Programs

Products in development by other pharmaceutical companies

Vosaroxin:ONCOLOGY

Phase 2 study of Vosaroxin as a treatment for patients with acute myeloid leukemia

Clinical Trial Info MOA Vosaroxin
Vosaroxin:ONCOLOGY

Phase 2 study of Vosaroxin as a treatment for women with platinum-resistant ovarian cancer

Clinical Trial Info MOA Vosaroxin
Clinical Trial Information
Get general information about clinical studies, and learn about Sunesis investigational drugs currently in clinical trial.
click here to learn more
Partnering
Strategic alliances allow us to expand our development and marketing efforts.
click here to learn more